Search research articles
Contact Us
Filters
Showing results (31-40 of 138) with videos related to
Page
of 14
Sort By:
Nature Reviews. Clinical Oncology
|
September 19, 2025
Next-generation T cell immunotherapies engineered with CRISPR base and prime editing: challenges and opportunities
Karl Petri, Elvira D'Ippolito, Annette Künkele, et al.
Angewandte Chemie (International Ed. in English)
|
April 25, 2020
Chemically Programmable and Switchable CAR-T Therapy
Junpeng Qi, Kohei Tsuji, David Hymel, et al.
Current Research in Translational Medicine
|
April 16, 2018
Novel targets and technologies for CAR-T cells in multiple myeloma and acute myeloid leukemia
Sabrina Prommersberger, Hardikkumar Jetani, Sophia Danhof, et al.
Leukemia & Lymphoma
|
November 24, 2023
BCMA CAR-T cells in multiple myeloma-ready for take-off?
Lukas Scheller, Erius Tebuka, Peter Fabian Rambau, et al.
Methods in Molecular Biology (Clifton, N.J.)
|
June 22, 2022
Generation of CAR-T Cells with Sleeping Beauty Transposon Gene Transfer
Sabrina Prommersberger, Razieh Monjezi, Lacramioara Botezatu, et al.
Frontiers in Oncology
|
August 28, 2020
CAR T-Cells in Multiple Myeloma: State of the Art and Future Directions
Luis Gerardo Rodríguez-Lobato, Maya Ganzetti, Carlos Fernández de Larrea, et al.
Blood
|
November 2, 2017
SLAMF7-CAR T cells eliminate myeloma and confer selective fratricide of SLAMF7<sup>+</sup> normal lymphocytes
Tea Gogishvili, Sophia Danhof, Sabrina Prommersberger, et al.
Journal of Visualized Experiments : Jove
|
June 29, 2026
Standardized Flow Cytometry Assay Using Dried Recombinant Antibody Panels for CAR T Cell Characterization
Annika Ridzal, Anja Brauchle, Desiré Missing, et al.
Nature Communications
|
July 19, 2019
Super-resolution microscopy reveals ultra-low CD19 expression on myeloma cells that triggers elimination by CD19 CAR-T
Thomas Nerreter, Sebastian Letschert, Ralph Götz, et al.
Hemasphere
|
July 8, 2026
From monoclonal to polyfunctional immunotherapy: Reprogramming CAR-T-cell therapy with oncolytic viruses in B-cell malignancies
Eduard Achim, Guy Ungerechts, Ciprian Tomuleasa, et al.
Page
of 14
Search research articles
Search
Showing results (31-40 of 138) with videos related to
Sort By:
Page
of 14
Nature Reviews. Clinical Oncology
|
September 19, 2025
Next-generation T cell immunotherapies engineered with CRISPR base and prime editing: challenges and opportunities
Karl Petri, Elvira D'Ippolito, Annette Künkele, et al.
Angewandte Chemie (International Ed. in English)
|
April 25, 2020
Chemically Programmable and Switchable CAR-T Therapy
Junpeng Qi, Kohei Tsuji, David Hymel, et al.
Current Research in Translational Medicine
|
April 16, 2018
Novel targets and technologies for CAR-T cells in multiple myeloma and acute myeloid leukemia
Sabrina Prommersberger, Hardikkumar Jetani, Sophia Danhof, et al.
Leukemia & Lymphoma
|
November 24, 2023
BCMA CAR-T cells in multiple myeloma-ready for take-off?
Lukas Scheller, Erius Tebuka, Peter Fabian Rambau, et al.
Methods in Molecular Biology (Clifton, N.J.)
|
June 22, 2022
Generation of CAR-T Cells with Sleeping Beauty Transposon Gene Transfer
Sabrina Prommersberger, Razieh Monjezi, Lacramioara Botezatu, et al.
Frontiers in Oncology
|
August 28, 2020
CAR T-Cells in Multiple Myeloma: State of the Art and Future Directions
Luis Gerardo Rodríguez-Lobato, Maya Ganzetti, Carlos Fernández de Larrea, et al.
Blood
|
November 2, 2017
SLAMF7-CAR T cells eliminate myeloma and confer selective fratricide of SLAMF7<sup>+</sup> normal lymphocytes
Tea Gogishvili, Sophia Danhof, Sabrina Prommersberger, et al.
Journal of Visualized Experiments : Jove
|
June 29, 2026
Standardized Flow Cytometry Assay Using Dried Recombinant Antibody Panels for CAR T Cell Characterization
Annika Ridzal, Anja Brauchle, Desiré Missing, et al.
Nature Communications
|
July 19, 2019
Super-resolution microscopy reveals ultra-low CD19 expression on myeloma cells that triggers elimination by CD19 CAR-T
Thomas Nerreter, Sebastian Letschert, Ralph Götz, et al.
Hemasphere
|
July 8, 2026
From monoclonal to polyfunctional immunotherapy: Reprogramming CAR-T-cell therapy with oncolytic viruses in B-cell malignancies
Eduard Achim, Guy Ungerechts, Ciprian Tomuleasa, et al.
Page
of 14